SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001615774-19-002510
Filing Date
2019-02-14
Accepted
2019-02-14 15:37:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A s116133_sc13ga.htm SC 13G/A 46695
  Complete submission text file 0001615774-19-002510.txt   48544
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81104 | Film No.: 19605483
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE SUITE 207 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE SUITE 207 PALO ALTO CA 94301 6506880818
Vivo Opportunity, LLC (Filed by) CIK: 0001728970 (see all company filings)

IRS No.: 823132352 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A